XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated income statements - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Consolidated income statements [Abstract]      
Revenue $ 1,102,029 $ 1,211,749 $ 1,013,260
Other operating income 80,782 74,670 99,525
Employee benefit expenses (80,232) (78,758) (54,464)
Depreciation, amortization, and impairment charges (473,638) (439,441) (408,604)
Other operating expenses (351,248) (414,330) (276,666)
Operating profit 277,693 353,890 373,051
Financial income 5,569 2,755 7,052
Financial expense (333,263) (361,270) (378,386)
Net exchange differences 10,257 1,873 (1,351)
Other financial income, net 6,503 15,750 40,875
Financial expense, net (310,934) (340,892) (331,810)
Share of profit of entities carried under the equity method 21,465 12,304 510
Profit/(loss) before income tax (11,776) 25,302 41,751
Income tax (expense)/income 9,689 (36,220) (24,877)
Profit/(loss) for the period (2,087) (10,918) 16,874
Profit attributable to non-controlling interests (3,356) (19,162) (4,906)
Profit/(loss) for the year attributable to the Company $ (5,443) $ (30,080) $ 11,968
Weighted average number of ordinary shares outstanding - basic (in shares) 114,695 111,008 101,879
Weighted average number of ordinary shares outstanding - diluted (in shares) 118,501 114,523 103,392
Basic earnings per share (in dollars per share) $ (0.05) $ (0.27) $ 0.12
Diluted earnings per share (in dollars per share) $ (0.05) [1] $ (0.27) [1] $ 0.12
[1] The potential ordinary shares related to the Green Exchangeable Notes and the ATM program have not been considered in the calculation of diluted earnings per share for the years 2022 and 2021 as they have an antidilutive effect.